News for Tandem Diabetes Care Stock (TNDM)

Diabetes stocks jump as obesity-drug recovery comes ahead of schedule, analysts say

Market Watch • 10/27/23

Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond

The Motley Fool • 10/26/23

ROSEN, A TOP RANKED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors with Losses to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM

PRNewsWire • 10/23/23

TNDM Shareholder Update: Johnson Fistel Encourages Tandem Diabetes Care Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline

Business Wire • 10/21/23

ROSEN, A LEADING NATIONAL FIRM, Encourages Tandem Diabetes Care, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TNDM

PRNewsWire • 10/16/23

Tandem Diabetes Care, Inc. (TNDM) Soars 6.0%: Is Further Upside Left in the Stock?

Zacks Investment Research • 10/16/23

Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023

Business Wire • 10/10/23

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM

PRNewsWire • 10/09/23

Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn

InvestorPlace • 10/04/23

Weight-Loss-Drug Stock Sting May Be Easing for Device Makers

Barrons • 10/02/23

2 Stocks Under $25 to Buy and Hold for 10 Years

The Motley Fool • 09/29/23

ROSEN, A LONGSTANDING LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - TNDM

PRNewsWire • 09/28/23

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

Accesswire • 09/27/23

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

Business Wire • 09/22/23

TNDM SHAREHOLDER ALERT: ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM

PRNewsWire • 09/22/23

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

Business Wire • 09/21/23

Medtech Makers Are the Real Losers From Obesity Drugs

Barrons • 09/21/23

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors

Business Wire • 09/19/23

Tandem Diabetes Care, Inc. (TNDM) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Tandem Diabetes Care, Inc. Securities Fraud Class Action

Business Wire • 09/18/23

TNDM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Business Wire • 09/18/23

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors

Business Wire • 09/18/23

TNDM INVESTOR ALERT: Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PRNewsWire • 09/16/23

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Tandem Diabetes Care, Inc. (TNDM) on Behalf of Investors

Business Wire • 09/15/23

TOP RANKED ROSEN LAW FIRM Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM

PRNewsWire • 09/14/23

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Tandem Diabetes Care, Inc. (TNDM) on Behalf of Investors

Business Wire • 09/14/23